Clinical Trial Update: A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced/Metastatic Soft Tissue and Bone Sarcoma [Phase 1]

View source ↗

Summary

First-in-human Phase 1 trial evaluating Attil12, a T-cell therapy with membrane-anchored IL-12, in patients with advanced soft tissue and bone sarcoma; recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Sarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Attil12 (T-cell membrane-anchored tumor-targeted interleukin-12)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Soft Tissue Sarcoma, Bone Sarcoma | Phase 1 | Status: RECRUITING